UNCY Unicycive Therapeutics reports wide Q4 2025 EPS miss shares dip slightly amid soft investor sentiment Amgen Inc AMGN Stem Cell Therapy Leadership Meets Balanced NearTerm Valuation Dynamics Middle East Geopolitical Disruption Spillover Risks to Asian Manufacturing and Global Commodity Markets